These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16216037)

  • 61. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
    Koch DG; Christiansen L; Lazarchick J; Stuart R; Willner IR; Reuben A
    Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma.
    Rinaldi A; Capello D; Scandurra M; Greiner TC; Chan WC; Bhagat G; Rossi D; Morra E; Paulli M; Rambaldi A; Rancoita PM; Inghirami G; Ponzoni M; Moreno SM; Piris MA; Mian M; Chigrinova E; Zucca E; Favera RD; Gaidano G; Kwee I; Bertoni F
    Br J Haematol; 2010 May; 149(4):569-77. PubMed ID: 20230398
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of human leukocyte antigen haplotypes with posttransplant lymphoproliferative disease after solid organ transplantation.
    Subklewe M; Marquis R; Choquet S; Leblond V; Garnier JL; Hetzer R; Swinnen LJ; Oertel S; Papp-Vary M; Gonzalez-Barca E; Hepkema BG; Schoenemann C; May J; Pezzutto A; Riess H
    Transplantation; 2006 Oct; 82(8):1093-100. PubMed ID: 17060859
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N; Adachi A; Mori T; Kamata H; Nakahara J; Yokoyama K; Yamada T; Kizaki M; Sakamoto M; Ikeda Y; Okamoto S
    Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Conjunctival posttransplantation lymphoproliferative disorder.
    Walton RC; Onciu MM; Irshad FA; Wilson TD
    Am J Ophthalmol; 2007 Jun; 143(6):1050-1. PubMed ID: 17524778
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B
    Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities.
    Djokic M; Le Beau MM; Swinnen LJ; Smith SM; Rubin CM; Anastasi J; Carlson KM
    Genes Chromosomes Cancer; 2006 Mar; 45(3):313-8. PubMed ID: 16283619
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Post-transplant multiple myeloma in a pediatric renal transplant patient.
    Tcheng WY; Said J; Hall T; Al-Akash S; Malogolowkin M; Feig SA
    Pediatr Blood Cancer; 2006 Aug; 47(2):218-23. PubMed ID: 16086426
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment for Epstein-Barr virus-associated PTLD.
    Gross TG
    Herpes; 2009 Jan; 15(3):64-7. PubMed ID: 19306606
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
    Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A case of fulminant post-transplant lymphoproliferative disorder and septicemia.
    Gouya G; Hartmann G; Faè P; Tauber M; Holzmüller H; Benzer W; Lang A; Schuster A; Drexel H; Offner FA
    Clin Transplant; 2006; 20(2):261-4. PubMed ID: 16640537
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
    Bakker NA; Verschuuren EA; Erasmus ME; Hepkema BG; Veeger NJ; Kallenberg CG; van der Bij W
    Transplantation; 2007 Feb; 83(4):433-8. PubMed ID: 17318076
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Microsatellite analysis of posttransplant lymphoproliferative disorders: determination of donor/recipient origin and identification of putative lymphomagenic mechanism.
    Larson RS; Scott MA; McCurley TL; Vnencak-Jones CL
    Cancer Res; 1996 Oct; 56(19):4378-81. PubMed ID: 8813129
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
    Babel N; Gabdrakhmanova L; Hammer M; Rosenberger C; Oppert M; Volk HD; Reinke P
    Transpl Infect Dis; 2005; 7(3-4):133-6. PubMed ID: 16390402
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders.
    Kabasawa N; Shiozawa E; Murai S; Homma M; Uesugi Y; Matsui T; Nakata A; Shimada S; Sasaki Y; Baba Y; Watanuki M; Arai N; Fujiwara S; Kawaguchi Y; Tsukamoto H; Uto Y; Yanagisawa K; Hattori N; Sakai H; Harada H; Nakamaki T; Takimoto M; Yamochi-Onizuka T
    J Clin Exp Hematop; 2021; 61(3):120-125. PubMed ID: 34511544
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lymphoma: risk and response after solid organ transplant.
    Jacobson CA; LaCasce AS
    Oncology (Williston Park); 2010 Sep; 24(10):936-44. PubMed ID: 21138175
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Extramedullary plasmacytoma-like posttransplantation lymphoproliferative disorders: clinical and pathologic features.
    Richendollar BG; Hsi ED; Cook JR
    Am J Clin Pathol; 2009 Oct; 132(4):581-8. PubMed ID: 19762536
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Quantitative Epstein-Barr virus viral load monitoring in pediatric liver transplantation.
    Jang JY; Kim KM; Lee YJ; Lee SG; Chi HS
    Transplant Proc; 2008 Oct; 40(8):2546-8. PubMed ID: 18929796
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
    Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
    Mendoza F; Kunitake H; Laks H; Odim J
    Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.